Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sinovant Sciences and Renexxion announced the initiation of a collaboration to pursue the development of naronapride, an investigational gastrointestinal prokinetic, in Greater China.
read more
Avondale Pharmaceuticals announced an exclusive, product development partnership with Oxford Pharmaceuticals, a pharmaceutical manufacturer and distributor based in Birmingham, AL.
read more
ProBioGen AG and Pionyr Immunotherapeutics have announced a second service and license agreement to develop novel antibody therapeutics.
read more
NeuroTrauma Sciences and Henry Ford Health System announced a newly-formed subsidiary of NTS has entered into multi-year Sponsored Research and License Agreements.
read more
We’ve seen the number of new drug shortages steadily decline since a peak in 2011 owing to the work of the FDA, industry and other groups.
read more
TrialCard, based in Morrisville, N.C., will expand its patient support services in Kansas City.
read more
Rockwell Medical provided an update regarding Calcitriol, the company's FDA approved active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis.
read more
Synteract acquired Cu-Tech a dermatology specialist CRO. The two companies have now created a dedicated center of dermatology development.
read more
PCI Pharma announced that Salim Haffar will join the company as Chief Executive Officer later this year.
read more
The Wasdell Group has launched its serialization service ahead of the EU FMD and US DSCSA implementation deadlines.
read more
SRI International announced a research agreement with Ionis, combining SRI's proprietary FOX Three Molecular Guidance cellular targeting system with Ionis' proprietary antisense drug-discovery platform.
read more
Highmark announced an outcomes-based contract with Boehringer Ingelheim for Jardiance, an oral medicine indicated to lower blood sugar in adults with type 2 diabetes.
read more
QIAGEN announced a partnership with multiple organizations to support creating a global genomics campus in Manchester, U.K.
read more
908 Devices announced a joint innovation partnership with Hangzhou Just Biotherapeutics.
read more
TFF Pharmaceuticals announced the USPTO has issued a Notice of Allowance for U.S. Patent Application No. 12/778,795, "Compositions and Methods of Making Brittle-Matrix Particles Through Blister Pack Freezing."
read more